Effect of NKCP on metabolic disorders

　　　　　　　　　

Fred Pescatore

“The effects of NKCP on metabolic disorders were investigated.
In this small scale open-label study, 13 subjects (5 men, 8 women, mean age 47.7 years) with metabolic disorders were administered NKCP 250 mg/day for 12 weeks. Total cholesterol (TC), HDL cholesterol, LDL cholesterol, triglyceride (TG), fibrinogen (Fbg), HbA1c, hs-CRP, and body weight were measured before and after the test period.
As a result, TC, LDL cholesterol, and TG were significantly reduced, suggesting that NKCP has a lipid metabolism improving effect. In addition, a significant decrease in HbA1c was observed, suggesting that NKCP may be effective against diabetes and pre-diabetes. In addition, a significant decrease in hs-CRP was also observed, indicating that NKCP has anti-inflammatory effects. Furthermore, it was shown that body weight was significantly reduced,and that it may have a weight-reducing effect.
These results suggest that NKCP is effective on improving lipid metabolism, anti-diabetic, anti-inflammatory, and body weight reduction, and is expected to contribute to the improvement of metabolic disorders.”

This page contains data that has been partially modified from the original graphs in the article for optimal display on the website.